Effects of trandolapril and verapamil on glucose transport in insulin- resistant rat skeletal muscle

Metabolism: Clinical and Experimental

Volumn 45, Issue 5, 1996, Pages 535-541

  Jacob, Stephan ^b   Henriksen, Erik J ^a   Fogt, Donovan L ^b   Dietze, Günther J ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER; GLYCOGEN; HEXOKINASE; INSULIN; TRANDOLAPRIL; VERAPAMIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HALF LIFE; ENZYME ACTIVITY; FEMALE; GLUCOSE TRANSPORT; GLYCOLYSIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MUSCLE METABOLISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

EID: 0029918750     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90021-9     Document Type: Article

References (47)

1. Ferrannini E, Buzzigoli G, Bonadona R, et al: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
2. Pollare T: Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition. J Diab Complic 4:75-78, 1990
3. Natali A, Santoro D, Palombo C, et al: Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17:170-178, 1991
4. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
5. Foster DW: Insulin resistance - A secret killer? N Engl J Med 320:733-734, 1989
6. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
7. Lithell HOL: Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14:203-209, 1991
8. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989
9. Pollare T, Lithell H, Selinus I, et al: Sensitivity to insulin during treatment with atenolol and nietoprolol: A randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 297:1152-1157, 1989
10. Pollare T, Lithell H, Mörin C, et al: Metabolic effects of diltiazem and atenolol: Results from a randomized, double-blind study with parallel groups. J Hypertens 7:551-559, 1989
11. Swislocki ALM, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 2:419-423, 1989
12. Pollare T, Lithell H, Selinus I, et al: Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31:415-420, 1988
13. Jauch KW, Hartl W, Günther B, et al: Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 17:448-454, 1987
14. Rett K, Lotz N, Wicklmayr M, et al: Verbesserte Insulinwirkung durch ACE-Hemmung beim Typ-II-Diabetiker. Dtsch Med Wochenschr 113:243-249, 1988
15. Torlone E, Rambotti AM, Perriello G, et al: ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 34:119-125, 1991
16. Fernere M, Lachkar H, Richard JL, et al: Captopril and insulin sensitivity. Ann Intern Med 102:134-135, 1985
17. Gans ROB, Biol HJG, Nauta JJP, et al: The effect of angiotensin-I converting enzyme inhibition on insulin action in healthy volunteers. Eur J Clin Invest 21:527-533, 1991
18. Allemann Y, Baumann S, Jost M, et al: Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinipril. Eur J Clin Pharmacol 42:275-280, 1992
19. Paolisso G, Gambardella A, Verza M, et al: ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J Human Hypertens 6:175-179, 1992
20. Shieh S-M, Sheu WH-H, Shen DD-C, et al: Improvements in metabolic risk factors for coronary heart disease associated with cilazapril treatment. Am J Hypertens 5:506-510, 1992
21. Uehara M, Kishikawa H, Isami S, et al: Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans. Diabetologia 37:300-307, 1994
22. Vuorinen-Markkola H, Yki-Järvinen H: Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 44:85-89, 1995
23. Jacob S, Warth B, Thies R, et al: Acute effects of various doses of captopril on glucose metabolism in humans. Third International Symposium on ACE Inhibition, Amsterdam, The Netherlands, March 19-23, 1993, p 3A.5 (abstr)
24. Henriksen EJ, Jacob S: Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats. Metabolism 44:267-272, 1995
25. Cohen H, Bruner HR: Pharmacological profile of trandolapril, a new angiotensin-converting enzyme inhibitor. Am Heart J 125:1525-1531, 1993
26. Bergmeyer HU, Bernt E, Schmidt F, et al: D-Glucose, in Bergmeyer HU (ed): Methods of Enzymatic Analysis. Deerfield Beach, FL, Verlag Chemie, 1981, pp 1196-1201
27. Hassid WZ, Abraham S: Chemical procedure for analysis of polysaccharides. Determination of glycogen and starch. Methods Enzymol 3:34-37, 1957
28. Henriksen EJ, Halseth AE: Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats. J Appl Physiol 76:1862-1867, 1994
29. Uyede K, Racker E: Regulatory mechanisms in carbohydrate metabolism. VII. Hexokinase and phosphofructokinase. J Biol Chem 240:4682-4688, 1965
30. Srere PA: Citrate synthase. Methods Enzymol 13:3-10, 1969
31. Henriksen EJ, Ritter LS: Effect of soleus unweighting on stimulation of insulin-independent glucose transport activity. J Appl Physiol 74:1653-1657, 1993
32. Gulve EA, Henriksen EJ, Rodnick KJ, et al: Glucose transporters and glucose transport in skeletal muscles of 1 to 25 month old rats. Am J Physiol 264:E319-E327, 1993
33. Henriksen EJ, Holloszy JO: Effect of diffusion distance on measurement of glucose transport in rat skeletal muscles in vitro. Acta Physiol Scand 143:381-386, 1991
34. Dzau VJ: Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 153:937-942, 1993
35. Cartee GD, Briggs-Tung C, Holloszy JO: Diverse effects of calcium channel blockers on skeletal muscle glucose transport. Am J Physiol 263:R70-R75, 1992
36. Guilgliano D, Sccomanno F, Paolisso G, et al: Nicardipine does not cause deterioration of glucose homeostasis in man: A placebo controlled study in elderly hypertensives with and without diabetes mellitus. Eur J Clin Pharmacol 43:39-45, 1992
37. Trost BN: Glucose metabolism and calcium antagonists. Horm Metab Res 22:89-95, 1990
38. Henriksen EJ, Bourey RE, Rodnick KJ, et al: Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol 259:E593-E598, 1990
39. King PA, Horton ED, Hirshman MF, et al: Insulin resistance in obese Zucker rat (fa/fa) is associated with a failure of glucose transporter translocation. J Clin Invest 90:1568-1575, 1993
40. Erdös EG: Angiotensin I converting enzyme. Circ Res 36:247-255, 1975
41. Dietze GJ: Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: Possible involvement of kinins and prostaglandins. Mol Cell Endocrinol 25:127-149, 1982
42. Nesher R, Karl IE, Kipnis DM: Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am J Physiol 249:C226-C232, 1985
43. Leighton B, Challis RAJ, Newsholme EA: Role of prostaglandins as modulators of insulin-stimulated glucose metabolism in skeletal muscle. Horm Metab Res 22:89-95, 1990
44. Kodama J, Katayama S, Tahaka K, et al: Effect of captopril on glucose concentration. Possible role of augmented postprandrial forearm blood flow. Diabetes Care 13:1109-1111, 1990
45. Hirooka Y, Imaizuma T, Masaki H, et al: Captopril improved impaied endothelium-dependent vasodilation in hypertensive patients. Hypertension 20:175-180, 1992
46. Waeber B, Juillerat-Jeanneret L, Aubert J-F, et al: Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors. Br J Pharmacol 27:1758-1808, 1989
47. Bao G, Gohlke P, Qadri F, et al: Chronic kinin blockade attenuates the antihypertensive effect of ramipril. Hypertension 20:74-79, 1992